Cardiovascular Risk in Subclinical Hypothyroidism

Mariana Dobrescu; Diana Păun; Daniel Grigorie; Cătălina Poiană

doi:10.2478/inmed-2018-0022

.blurhash-client-img { display: none !important; }

Cardiovascular Risk in Subclinical Hypothyroidism

Internal Medicine

Volume 15 (2018): Issue 3 (July 2018)

By: Mariana Dobrescu, Diana Păun, Daniel Grigorie and Cătălina Poiană

Open Access

|Jul 2018

Abstract

Subclinical hypothyroidism (HSC) is a relatively common thyroid dysfunction, characterized by the increase of the thyroid stimulating hormone (TSH) in the presence of normal free thyroxine values. Thyroid hormones are known for the cardiovascular effects, and the consequences of HSC on the cardiovascular system have become the focus of many studies lately. There are clear indications of the relationship between HSC and cardiovascular risk factors such as hypertension, dyslipidemia and atherosclerosis; also, HSC is associated with metabolic syndrome, BMI increase and cardiac insufficiency. Therefore, many clinical trials investigate the benefits and risks of HSC treatment with L-thyroxine.

References

1. Cooper DS, Biondi B. Subclinicalthyroiddisease. Lancet 2012;379:1142–1154.10.1016/S0140-6736(11)60276-6
Search in Google Scholar Back to article
2. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinicalthyroiddisease: scientific review and guidelines for diagnosis and management. JAMA 2004;291:228–238.10.1001/jama.291.2.22814722150
Search in Google Scholar Back to article
3. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. EndocrRev 2008;29:76–131.10.1210/er.2006-004317991805
Search in Google Scholar Back to article
4. Park YJ, Lee YJ, Choi SI, Chun EJ, Jang HC, Chang HJ. Impact of subclinical hypothyroidism on the coronary artery disease in apparently healthy subjects. Eur J Endocrinol 2011;165:115–121.10.1530/EJE-11-001421490120
Search in Google Scholar Back to article
5. Kim YA, Park YJ. Prevalence and risk factors of subclinical thyroid disease. EndocrinolMetab (Seoul) 2014;29:20–29.10.3803/EnM.2014.29.1.20397028224741450
Search in Google Scholar Back to article
6. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526–534.10.1001/archinte.160.4.52610695693
Search in Google Scholar Back to article
7. Kim TH, Choi HS, Bae JC, Moon JH, Kim HK, Choi SH, et al. Subclinical hypothyroidism in addition to common risk scores for prediction of cardiovascular disease: a 10-year community-based cohort study. Eur J Endocrinol 2014;171:649-657.10.1530/EJE-14-046425184283
Search in Google Scholar Back to article
8. Vanderpump MP, Tunbridge WM, French JM, Apple-ton D, Bates D, Clark F et al. The incidence of thyroid disorders in the community: a twenty year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995;43:55–68.10.1111/j.1365-2265.1995.tb01894.x7641412
Search in Google Scholar Back to article
9. Teng W, Shan Z, Teng X, Guan H, Li Y, Teng D et al. Effect of iodine intake on thyroid diseases in China. NEngl J Med 2006;354:2783–2793.10.1056/NEJMoa05402216807415
Search in Google Scholar Back to article
10. Al Sayed A, Al Ali N and Alfadhli E. Subclinical hypothyroidism is associated with early insulin resistance in Kuwaiti women. Endocr J 2006;53:653-657.10.1507/endocrj.K06-018
Search in Google Scholar Back to article
11. Ridker PM, RifaiN, Stampfer MJ and Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation2000;101:1767-1772.10.1161/01.CIR.101.15.176710769275
Search in Google Scholar Back to article
12. Esper RJ, Nordaby RA, Vilariño JO, Paragano A, Cacharrón JL, Machado RA. Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol2006; 5:4–22.10.1186/1475-2840-5-4
Search in Google Scholar Back to article
13. Widlansky ME, Gokce N, Keaney JFJr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol2003;42:1149–1160.10.1016/S0735-1097(03)00994-X
Open DOI Search in Google Scholar Back to article
14. Frank PG, Pavlides S, Lisanti MP. Caveolae and transcytosis in endothelial cells: role in atherosclerosis. CellTissue Res2009;335:41–47.10.1007/s00441-008-0659-818688651
Search in Google Scholar Back to article
15. Tseng FY, Lin WY, Lin CC, et al. Subclinical hypothyroidism is associated with increased risk for all cause and cardiovascular mortality in adults. J Am CollCardiol 2012;60:730-737.10.1016/j.jacc.2012.03.04722726629
Search in Google Scholar Back to article
16. Gen R, Akbay E and Sezer K. Insulin resistance and cardiovascular risk factors in patient with mild and severe subclinical hypothyroidism. The Endocrinologist 2010;20:128-130.10.1097/TEN.0b013e3181dfe618
Search in Google Scholar Back to article
17. Maratou E, Hadjidakis DJ, Kollias A, et al. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol 2009;160:785-790.10.1530/EJE-08-079719141606
Search in Google Scholar Back to article
18. Peeters RP, Van DerDeure WM, Van Den Beld AW, et al. The Asp727Glu polymorphism in the TSH receptor is associated with insulin resistance in healthy elderly men. Clin Endocrinol (Oxf) 2007;66:808-815.10.1111/j.1365-2265.2007.02817.x17408423
Search in Google Scholar Back to article
19. XiangGD, Xiang LW, He HL and Zhao LS. Postprandial lipaemia suppresses endothelium-dependent arterial dilation in patients with hypothyroidism. Endocrine 2012;42:391-398.10.1007/s12020-012-9624-022354717
Open DOI Search in Google Scholar Back to article
20. Taddei S, Caraccio N, Virdis A, et al. Low grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto’s thyroiditis. J Clin EndocrinolMetab 2006;91:5076-5082.10.1210/jc.2006-107516968790
Search in Google Scholar Back to article
21. Zhang C, Xu X, Potter BJ, et al. TNF-alpha contributes to endo-thelial dysfunction in ischemia/reperfusion injury. ArteriosclerThrombVasc Biol 2006;26:475-480.10.1161/01.ATV.0000201932.32678.7e16385082
Search in Google Scholar Back to article
22. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A and Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med 2000;132:270-278.10.7326/0003-4819-132-4-200002150-0000410681281
Search in Google Scholar Back to article
23. Rodondi N, Newman AB, Vittinghoff E, et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 2005;165:2460-2466.10.1001/archinte.165.21.246016314541
Search in Google Scholar Back to article
24. Walsh JP, Bremner AP, Bulsara MK, et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med 2005;165:2467-2472.10.1001/archinte.165.21.246716314542
Search in Google Scholar Back to article
25. Razvi S, Weaver JU, Vanderpump MP and Pearce SH. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. J Clin EndocrinolMetab 2010;95:1734-1740.10.1210/jc.2009-174920150579
Search in Google Scholar Back to article
26. Dardano A, Ghiadoni L, Plantinga Y, et al. Recombinant human thyrotropin reduces endothelium dependent vasodilation in patients monitored for differentiated thyroid carcinoma. J Clin EndocrinolMetab 2006;91:4175-4178.10.1210/jc.2006-044016868055
Search in Google Scholar Back to article
27. Kim YA, Montagnani M, Koh KK and Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction molecular and pathophysiological mechanisms. Circulation 2006;113:1888-1904.10.1161/CIRCULATIONAHA.105.56321316618833
Search in Google Scholar Back to article
28.Kvetny J, Heldgaard PE, Bladbjerg EM, Gram J. Subclinical hypothyroidism is associated with a low grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol (Oxf) 2004;61:232–238.10.1111/j.1365-2265.2004.02088.x15272919
Open DOI Search in Google Scholar Back to article
29. Rodondi N, den ElzenWP, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. Journal of the American Medical Association 2010;304:1365–1374.10.1001/jama.2010.1361392347020858880
Search in Google Scholar Back to article
30. Gencer B, Collet TH, Virgini V, Auer R &Rodondi N. Subclinical thyroid dysfunction and cardiovascular outcomes among prospective cohort studies. Endocrine, Metabolic &ImmuneDisorders Drug Targets 2013;13:4–12.10.2174/187153031131301000323369133
Search in Google Scholar Back to article
31. McQuade C, Skugor M, Brennan DM, Hoar B, Stevenson C & Hoogwerf BJ. Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a précis database study. Thyroid 2011;21: 837–843.10.1089/thy.2010.029821745107
Open DOI Search in Google Scholar Back to article
32. Taylor PN, Razvi S, Pearce SH, Dayan CM. Clinical review: a review of the clinical consequences of variation in thyroid function within the reference range. J Clin EndocrinolMetab 2013;98:3562-3571.10.1210/jc.2013-1315
Search in Google Scholar Back to article
33. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. New England Journal of Medicine 2008;358:1336-1345.10.1056/NEJMoa072100
Search in Google Scholar Back to article
34. Geng H, Zhang X, Wang C, et al. Even mildly elevated TSH is associated with an atherogenic lipid profile in postmenopausal women with subclinical hypothyroidism. Endocr Res2014;28:625-631.
Search in Google Scholar Back to article
35. Brenta G, Mutti LA, Schnitman M, Fretes O, Perrone A, Matute ML. Assessment of left ventricular diastolic function byradionuclideventriculography at rest and exercise in subclinical hypothyroidism, and its response to L-thyroxine therapy. AmJ Cardiol2003;91:1327–1330.10.1016/S0002-9149(03)00322-9
Search in Google Scholar Back to article
36. Nanchen D, Gussekloo J, Westendorp RG, Stott DJ, Jukema JW, Trompet S, et al. Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. J Clin Endocrinol Metab2012;97:852–861.10.1210/jc.2011-197822238391
Open DOI Search in Google Scholar Back to article
37. Madathil A, Hollingsworth KG, Blamire AM, Razvi S, Newton JL, Taylor R, et al. Levothyroxine improves abnormal cardiac bioenergetics in subclinical hypothyroidism: a cardiac magnetic resonance spectroscopic study. J Clin Endocrinol Metab 2015; 100: E607–E610.10.1210/jc.2014-294225541742
Search in Google Scholar Back to article
38. Iqbal A, Figenschau Y, Jorde R. Blood pressure in relation to serum thyrotropin: the Tromsø study. J HumHypertens 2006;20:932–936.10.1038/sj.jhh.100209117024137
Search in Google Scholar Back to article
39. Liu D, Jiang F, Shan Z, Wang B, Wang J, Lai Y, et al. A cross sectional survey of relationship between serum TSH level and blood pressure. J HumHypertens 2010;24:134–138.10.1038/jhh.2009.44301109419554027
Search in Google Scholar Back to article
40. Monzani F, Caraccio N, Kozakowa M, et al. Effect of levothyroxine replacement on lipid profile and intima media thickness in subclinical hypothyroidism: a double blind, placebo-controlled study. J Clin Endocrinol Metab2004;89:2099–2106.10.1210/jc.2003-03166915126526
Search in Google Scholar Back to article
41. Oner FA, Yurdakul S, Oner E, Uzum AK, Erguney M. Evaluation of the effect of L-thyroxin therapy on endothelial functions in patients with subclinical hypothyroidism. Endocr Res2011;40:280–284.10.1007/s12020-011-9465-221505892
Open DOI Search in Google Scholar Back to article
42. Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 2003;88:2438–2444.10.1210/jc.2003-03039812788839
Open DOI Search in Google Scholar Back to article
43. Saltiki K, Voidonikola P, Stamatelopoulos K, MantzouE, Papamichael C, AlevizakiM. Association of thyroid function with arterial pressure in normotensive and hypertensive euthyroid individuals: a cross sectional study. ThyroidRes 2008;29:3–9.10.1186/1756-6614-1-3
Search in Google Scholar Back to article
44. Iwen KA, Schroder E, Brabant G. Thyroid hormones and the metabolic syndrome. EurThyroid J 2013;2:83–92.10.1159/000351249
Search in Google Scholar Back to article
45. Nakajima Y, Yamada M, Akuzawa M, Ishii S, Masamura Y, Satoh T, et al. Subclinical hypothyroidism and indices for metabolic syndrome in Japanese women: one year followup study. J Clin EndocrinolMetab 2013;98:3280–3287.10.1210/jc.2013-1353
Search in Google Scholar Back to article
46. Suh S, Lee MK. Metabolic syndrome and cardiovascular disease in Korea. J. Atheroscler. Thromb 2014;21(Suppl 1):S31-S35.10.5551/jat.21_Sup.1-S31
Search in Google Scholar Back to article
47. Sari R, Balci MK, Altunbas H, Karayalcin U. The effect of bodyweight and weight loss on thyroid volume and function i n obese women. Cl i n Endocrinol 2003;59:258–262.10.1046/j.1365-2265.2003.01836.x
Search in Google Scholar Back to article
48. Rosenbaum M, Hirsch J, Murphy E, Leibel RL. Effects of changes in body weight on carbohydrate metabolism, catecholamine excretion, and thyroid function. Am J Clin Nutr 2000; 71:1421–1432.10.1093/ajcn/71.6.1421
Search in Google Scholar Back to article
49. Auwerx J, Staels B. Leptin. Lancet 1998; 351:737–742.10.1016/S0140-6736(97)06348-4
Search in Google Scholar Back to article
50. Ortiga-Carvalho TM, Oliveira KJ, Soares BA, Pazos-Moura CC. The role of leptin in the regulation of TSH secretion in the fed state: in vivo and in vitro studies. J Endocrinol 2002;174: 121–125.10.1677/joe.0.174012112098670
Search in Google Scholar Back to article
51. Ghizzoni L, Mastorakos G, Ziveri M, Furlini M, Solazzi A, Vottero A et al. Interactions of leptin and thyrotropin 24-h secretory profiles in short normal children. J Clin EndocrinolMetab 2001;86:2065–2072.10.1210/jcem.86.5.745211344208
Search in Google Scholar Back to article
52. Ye Y, Xie H, Zeng Y, Zhao X, Tian Z, Zhang S. Association between subclinical hypothyroidism and blood pressure: a meta-analysis of observational studies. EndocrPract 2014;20:150-158.10.4158/EP13237.OR24014003
Search in Google Scholar Back to article
53. Razvi S, Ingoe L, Keeka G, Oates C, McMillan C and Weaver JU: The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin EndocrinolMetab 2007;92:1715-1723.10.1210/jc.2006-186917299073
Search in Google Scholar Back to article
54. Razvi S, Weaver JU, Butler TJ, Pearce SH. Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Arch Intern Med2012;178:811–817.10.1001/archinternmed.2012.115922529180
Search in Google Scholar Back to article
55. Pasqualetti G, Tognini S, Polini A, Caraccio N, Monzani F. Is subclinical hypothyroidism a cardiovascular risk factor in the elderly? J Clin Endocrinol Metab2013;98:2256–2266.10.1210/jc.2012-381823559085
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.2478/inmed-2018-0022 | Journal eISSN: 1220-5818 | Journal ISSN: 1220-5818

Journal RSS Feed

Language: English

Page range: 51 - 60

Published on: Jul 20, 2018

Published by: Romanian Society of Internal Medicine

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

subclinical hypothyroidism,

cardiovascular risk factors,

L-thyroxine substitution therapy

Related subjects:

Medicine,

Clinical medicine,

Internal medicine,

Internal medicine, other,

Cardiology,

Gastroenterology,

Pneumology

© 2018 Mariana Dobrescu, Diana Păun, Daniel Grigorie, Cătălina Poiană, published by Romanian Society of Internal Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 15 (2018): Issue 3 (July 2018)